Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Glaucoma: Overview01:25

Glaucoma: Overview

1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification.

Bioactive materials·2021
Same author

Low-concentration povidone-iodine for the prevention of intraocular infections in ophthalmic surgery.

Current opinion in ophthalmology·2021
Same author

Glaucomatous or Non-glaucomatous Optic Neuropathy-It Is a Question?

American journal of ophthalmology·2021
Same author

Analysis of visual disability in Buenos Aires, Argentina. Pathologic myopia is the leading cause in working age.

Medicina·2021
Same author

Pioneers in neurology: Charles Miller Fisher (1913-2012).

Journal of neurology·2021
Same author

The 100 most-cited papers on age-related macular degeneration: a bibliographic perspective.

BMJ open ophthalmology·2021

Related Experiment Video

Updated: Mar 11, 2026

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
05:19

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

1.7K

Dropless Cataract Surgery: An Overview.

Richard L Lindstrom1, M Stewart Galloway2, Andrzej Grzybowski3

  • 1Minnesota Eye Consultants, 9801 Dupont Ave S., Suite 200, Bloomington, MN 55431. United States.

Current Pharmaceutical Design
|November 30, 2016
PubMed
Summary
This summary is machine-generated.

Dropless cataract surgery, involving intravitreal injection, offers a promising alternative to traditional topical eye drops. This approach aims to improve patient compliance and reduce risks associated with postoperative care.

Keywords:
Cataract surgeryantibiotic prophylaxiscompliancecorticosteroidendophthalmitisintracameralintravitrealtranszonular injection

More Related Videos

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
04:59

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

3.1K
A Novel Technique of Rescuing Capsulorhexis Radial Tear-out using a Cystotome
04:38

A Novel Technique of Rescuing Capsulorhexis Radial Tear-out using a Cystotome

Published on: January 16, 2011

13.8K

Related Experiment Videos

Last Updated: Mar 11, 2026

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
05:19

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

1.7K
Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
04:59

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

3.1K
A Novel Technique of Rescuing Capsulorhexis Radial Tear-out using a Cystotome
04:38

A Novel Technique of Rescuing Capsulorhexis Radial Tear-out using a Cystotome

Published on: January 16, 2011

13.8K

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Pharmacology

Background:

  • Postoperative topical eye drops are crucial for cataract surgery outcomes but pose challenges in patient compliance and adherence.
  • Noncompliance or improper instillation of eye drops can lead to complications and the development of antibiotic resistance.
  • The limitations of topical therapy necessitate the exploration of alternative prophylactic methods in cataract surgery.

Purpose of the Study:

  • To review the rationale behind reducing topical therapy in cataract surgery prophylaxis.
  • To evaluate the efficacy and safety of the "dropless cataract surgery" approach.
  • To discuss emerging strategies for minimizing or eliminating the need for postoperative eye drops.

Main Methods:

  • Literature review of studies on cataract surgery prophylaxis.
  • Analysis of data regarding intracameral injections, sustained-release drug delivery, and intravitreal injections.
  • Examination of the "dropless cataract surgery" technique involving compounded antibiotic and corticosteroid combinations.

Main Results:

  • Emerging approaches like intracameral injection and sustained-release mechanisms aim to reduce reliance on topical drops.
  • "Dropless cataract surgery" utilizes intravitreal injections as a single-dose alternative for prophylaxis.
  • The review assesses the current evidence on the effectiveness and safety profile of these novel methods.

Conclusions:

  • Reducing topical therapy in cataract surgery is a significant goal driven by compliance, cost, and resistance concerns.
  • "Dropless cataract surgery" presents a viable option, but further research on its long-term efficacy and safety is warranted.
  • Innovations in drug delivery are transforming postoperative care in cataract surgery, potentially enhancing patient outcomes.